Editor's note:

In response to the Belt and Road Initiative, and with the aim of sharing expertise and addressing shared health challenges, our hospital has launched the Overseas Promotion Program for New Medical Technologies. If you are interested in any of the medical technologies covered under this program, please feel free to contact the International Cooperation Office at faowch@163.com.

Brain Physiology and Cognitive Function Auxiliary Assessment Technology Promotion

1.  Technology Name
Eye Movement-Based Auxiliary Assessment Technology for Brain Physiology and Cognitive Function

2.  Technology Description
This technology underwent clinical validation and promotion through the Department of Neurology of West China Hospital. It has obtained the Sichuan Province Innovative Medical Device certification and the world's first medical device certificate for brain function assessment based on eye movement. Furthermore, it has acquired medical device registration in Thailand. Currently, it enables the auxiliary diagnosis and screening of cognitive impairment, Parkinson's disease, epilepsy, and autism spectrum disorder.

3.  Clinical Application Effectiveness & Innovations
This technology is non-invasive, requires only 3-5 minutes for screening, is easy to operate, cost-effective, and highly accurate. Compared to traditional subjective scales, it offers significant advantages as an objective assessment technology for brain function-related disorders.

4.  Promotion Value
Neurological disorders, especially major chronic neurological diseases, affect hundreds of millions of people globally. The number of individuals with Mild Cognitive Impairment worldwide is as high as 150 million, Parkinson's disease affects over 10 million, Autism Spectrum Disorder affects 100 million, and Epilepsy affects 70 million. Early screening, diagnosis, and treatment of major chronic neurological diseases have become a global consensus. However, a lack of early screening technologies means many neurological disorders are detected only at later stages, missing the optimal intervention window. This increases the societal burden and reduces the effectiveness of interventions. Eye movement technology offers distinct advantages in objectivity and early detection for neurological disorders, positioning it to contribute significantly to addressing the shared challenges related to aging populations ("the old") and neurodevelopmental conditions ("the young") in Belt and Road countries. Projects that align with local high-prevalence disease patterns will be prioritized for recommendation.